Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsPemolineMethylphenidatePropylaminesAdrenergic Uptake InhibitorsDrug UtilizationMedication ErrorsMedication AdherenceMedication ReconciliationMedication SystemsMedication Systems, HospitalPrescription DrugsDrug PrescriptionsSelf MedicationPatient ComplianceDrug TherapyPolypharmacyPsychotropic DrugsAntipsychotic AgentsAttention Deficit and Disruptive Behavior DisordersTreatment OutcomeConduct DisorderUnited StatesNonprescription DrugsComorbidityAntihypertensive AgentsDrug-Related Side Effects and Adverse ReactionsPsychiatric Status Rating ScalesPharmacistsClinical Pharmacy Information SystemsQuestionnairesNeuropsychological TestsPharmaceutical PreparationsAntidepressive AgentsDiagnostic and Statistical Manual of Mental DisordersRisk FactorsRetrospective StudiesMedical Order Entry SystemsSeverity of Illness IndexDrug Therapy, Computer-AssistedCross-Sectional StudiesDrug CostsInhibition (Psychology)Electronic PrescribingDextroamphetamineInsurance, Pharmaceutical ServicesFollow-Up StudiesDouble-Blind MethodPhysician's Practice PatternsAnti-Asthmatic AgentsProspective StudiesImpulsive BehaviorPharmaceutical ServicesCohort StudiesPharmacy Service, HospitalLongitudinal StudiesParentsReceptors, Dopamine D4Community Pharmacy ServicesDopamine Plasma Membrane Transport ProteinsAge FactorsDrug MonitoringDrug LabelingInappropriate PrescribingExecutive FunctionPatient Education as TopicTime FactorsTreatment RefusalPrescription FeesSubstance-Related DisordersAttentionBipolar DisorderPrevalenceCase-Control StudiesAsthmaOff-Label UsePharmaciesSchizophrenia